Manufacturer Supply of (-) -Huperzine a CAS 102518-79-6 for Alzheimer Treatment

Product Details
Customization: Available
CAS No.: 102518-79-6
Formula: C15h18n2o
Still deciding? Get samples of $ !
Request Sample
Diamond Member Since 2012

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Number of Employees
11
Year of Establishment
2012-08-09
  • Manufacturer Supply of (-) -Huperzine a CAS 102518-79-6 for Alzheimer Treatment
  • Manufacturer Supply of (-) -Huperzine a CAS 102518-79-6 for Alzheimer Treatment
  • Manufacturer Supply of (-) -Huperzine a CAS 102518-79-6 for Alzheimer Treatment
  • Manufacturer Supply of (-) -Huperzine a CAS 102518-79-6 for Alzheimer Treatment
  • Manufacturer Supply of (-) -Huperzine a CAS 102518-79-6 for Alzheimer Treatment
  • Manufacturer Supply of (-) -Huperzine a CAS 102518-79-6 for Alzheimer Treatment
Find Similar Products

Basic Info.

Model NO.
102518-79-6
EINECS
600-320-6
Type
Pharmaceutical Intermediates
Appearance
Powder
Quality
Industrial
Colour
White
Melting Point
211-216 Celsius Degree
Density
1.20 g/cm3(Predicted)
Storage
Keep in Dark Place, 2-8 Ceicius Degree
Solubility
Slightly Soluble in DMSO and Etoh
Pka
12.25
Transport Package
as Required
Specification
USP-40
Trademark
Worldyang
Origin
China
HS Code
2933790099

Product Description

(-)-Huperzine A
CAS: 102518-79-6
Appearance: White powder
Certifications: ISO9001:2015; GMP
Specifications: USP-40

Overview
(-)-Huperzine A is a natural alkaloid extracted from the Chinese herbal plant Huperzia serrata. It is a potent, reversible, and highly selective second-generation acetylcholinesterase inhibitor, successfully used in the treatment of Alzheimer's disease.

Currently, (-)-Huperzine A is primarily obtained through plant extraction and chemical synthesis. However, the wild Huperzia serrata resource is nearly depleted due to overharvesting, and the plant is difficult to cultivate on a large scale. Sustainable Huperzia serrata resources are facing severe scarcity. Moreover, chemical extraction and synthesis are complex, environmentally polluting, low-yielding, and costly.

Research Achievements
Our research team has made significant breakthroughs in addressing these challenges. We have cloned 12 enzyme-encoding genes from the endophytic fungus Shiraia sp. Slf14, which is associated with (-)-Huperzine A production. Using these genes, we successfully reconstructed the biosynthetic pathway of (-)-Huperzine A in Saccharomyces cerevisiae. Fermentation experiments confirmed the production of (-)-Huperzine A.

These advancements pave the way for the application of synthetic biology techniques, such as pathway reconstruction and regulatory network engineering, to achieve high-efficiency microbial synthesis of (-)-Huperzine A. This approach is expected to significantly improve fermentation yields and support sustainable, large-scale production.


Manufacturer Supply of (-) -Huperzine a CAS 102518-79-6 for Alzheimer TreatmentManufacturer Supply of (-) -Huperzine a CAS 102518-79-6 for Alzheimer TreatmentManufacturer Supply of (-) -Huperzine a CAS 102518-79-6 for Alzheimer TreatmentManufacturer Supply of (-) -Huperzine a CAS 102518-79-6 for Alzheimer TreatmentManufacturer Supply of (-) -Huperzine a CAS 102518-79-6 for Alzheimer TreatmentManufacturer Supply of (-) -Huperzine a CAS 102518-79-6 for Alzheimer TreatmentManufacturer Supply of (-) -Huperzine a CAS 102518-79-6 for Alzheimer Treatment

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier